Dr Lal PathLabs Q3: Net Profit Dips 6%, Revenue Jumps 11%

• Dr Lal PathLabs reported a mixed financial performance for the December quarter (Q3).
• Net profit for Q3 dropped by 6.4% year-on-year to ₹90.5 crore, down from ₹96.7 crore.
• Revenue for the same quarter increased by 10.8% to ₹660 crore, up from ₹595.7 crore.
• Operating performance showed strength, with EBITDA rising 17.3% year-on-year to ₹179 crore.
• EBITDA margin expanded to 27.1% in Q3, compared to 25.6% in the previous year.

Why It Matters: Dr Lal PathLabs saw Q3 net profit fall but revenue and EBITDA grow, indicating strong operational efficiency.